← Back to Patent Explorer
US4735945A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for inhibiting bone resorption and collagenase release

Assignee: Vipont Pharmaceutical Inc
•
Filing: 1986-03-13
•
Granted: 1988-04-05
•
Expires: 2006-03-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method of inhibiting bone resorption and collagenase release in mammalian periodontal subjects using a benzo-c-phenanthridine alkaloid compound.

Inventors

  • 👤 Seizaburo Sakamoto
  • 👤 Masako Sakamoto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:52
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 38 words
A method of inhibiting bone resorption and collagenase activity in mammals having periodontal disease, comprising adminstering to said mammals in amount from about 0.2 to about 20 umol/L of sanguinarine, sanguinarine pseudoethanolate or mixtures thereof dissolved in dimethylsulfoxide.
Claim 2
Independent Claim 38 words
A method of inhibiting bone resorption and collagenase activity in mammals having periodontal disease, comprising adminstering to said mammals in amount from about 0.2 to about 20 umol/L of sanguinarine, sanguinarine pseudoethanolate or mixtures thereof dissolved in dimethylsulfoxide.
Claim 3
Dependent Claim 19 words
The method of claim 1 wherein said sanguinarine is administered in amounts from about 1 to about 20 umol/L.
Claim 4
Dependent Claim 19 words
The method of claim 1 wherein sanguinarine pseudoethanolate is administered in amounts from about 0.2 to about 20 umol/L.
Claim 5
Dependent Claim 14 words
The method of claim 2 wherein sanguinarine is administered in amount of 20 umol/L.
Claim 6
Dependent Claim 15 words
The method of claim 4 wherein sanguinarine pseudoethanolate is administered in amounts of 5 umol/L.

References Cited (Backward Citations)

US4256743A Cited
US4406881A Cited
US4599228A Cited
US4569837A Cited
US4517172A Cited
US4590061A Cited
US4683133A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-04-05 1991-10-05 1992-04-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-04-05 1995-10-05 1996-04-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-04-05 1999-10-05 2000-04-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag